1. Top of page

Prostate cancer is an increasing burden in the European Union; it is not only the most common men’s cancer, but remains the second or third leading cause of cancer mortality in men, and has the highest prevalence of all cancers, with 2 million men living with prostate cancer. The ageing of the population will increase this burden, and several unsolved questions in the detection and management of the disease add substantially to compromising the quality of life of senior citizens. The long natural and treated history of prostate cancer provides a major cause of anxiety and distress to the patients. They need to learn that control of cancer is sometimes a preferred option to cure, and patient-centred care, with optimum treatment, is needed to increase the psychological, emotional, social and financial support to direct the choice of the right treatment for the right patient.

Europa Uomo, the European Prostate Cancer Coalition, was founded in 2004 in Milan, with the support of the European School of Oncology and the Oncological Centre Antwerp. Its mission includes the mobilization of and solidarity among all men, to raise awareness and education, early detection and access to optimum treatment, and promote research in the professional community of prostate cancer. This consensus started with 10 key policy options that we consider the focus of our goals, and that became known as the Manifesto of Europa Uomo (Appendix).

It is no surprise that quality of life is listed as the first priority, while peer support and partnerships with peer and professional associations are a constant in our future policies. The idea was enthusiastically received and now we have representatives in 18 European countries (Table 1), while we have established collaboration with the European Association of Urology, the European Society of Medical Oncology, the International Union against Cancer and, last but not least, the European Coalition of Cancer Patients. Our members look towards common projects of interest in the European Union, e.g. seeking organized information and education from the professional groups, the European Prostate Passport project, and setting up a reliable objective website

Table 1.  Member organizations of Europa Uomo; (Romania in preparation) and the names of their representatives. Each association assigns a voting member to each Annual General Assembly, allowing for flexible, representative democratic decision-making
AustriaSelbsthilfe ProstatakrebsE. Buechler
BelgiumUS TOO Belgium (Wij Ook België)L. Denis
Czech RepublicArcus – Onko CentrumJ. Kozelska
DenmarkPROPAE.P. Pyndt
FinlandPROPOH. Tavio
FranceANAMACaPR. Muntz
GermanyBundesverband Prostatakrebs Selbsthilfe e.VC. Ligensa
IrelandMen Against CancerT. Hudson
ItalyEuropa Uomo ItalyF. Sereni
NorwayPROFO NorwayJ. Christie
PolandGladiatorT. Wlodarczyk
PortugalAssociação Portuguesa dos Doentes da PróstataA. Pereira Pinto
RomaniaInstitute of Oncology BucharestS. Colovai
Slovak RepublicEuropa Uomo SlovakiaV. Koprda
SpainFefocE. Valverde
SwedenProstatacancerförbundetL. Eliason
NetherlandsUS TOO Forum – Epcel NlT. Eggenhuizen
SCPJ. van der Oord
UKProstate Cancer Support FederationM. Lockett

Despite our enthusiasm and our global aspirations to form a Worldwide Prostate Cancer Association for patient groups, we are not attempting to create a ‘European Unity’ group, as our membership has the autonomy to run their national programmes respecting the traditional and cultural differences that exist in Europe.

Europa Uomo is an international, independent, non-profit association of patient-led prostate cancer support groups. Its general assembly is the statutory decision-making body of the Coalition while an eight-member Steering Committee controls policies and initiatives. We are here to stay and we look forward to receiving sympathy and support from the professional community and civil society.


  1. Top of page

The Manifesto of Europa Uomo

  • 1
    To find ways and means to promote quality of life for patients with prostate cancer and their families.
  • 2
    To promote the dissemination and exchange of evidence-based as well as factual and up-to-date information on prostate cancer.
  • 3
    To promote prostate awareness and appropriate diagnosis and prognosis.
  • 4
    To emphasize the need for appropriate early detection.
  • 5
    To campaign for provision of and access to optimum treatment.
  • 6
    To ensure high-quality, supportive care throughout and after treatment.
  • 7
    To promote multi-professional quality care and appropriate medical infrastructure.
  • 8
    To acknowledge good clinical practice and promote its development.
  • 9
    To ensure that all men fully understand any proposed treatment options, including entry into clinical trials and their right to a second opinion.
  • 10
    To promote the advancement of prostate cancer research.